Showing results (1281-1290 of 2,642) with videos related to
Sort By:
Pageof 265
Hematology (Amsterdam, Netherlands)|January 13, 2023
Expert opinion paper on the treatment of hemophilia a with emicizumabFrancisco-José López-Jaime, Olga Benítez, Bolívar Luis Díaz Jordán, et al.Hematology (Amsterdam, Netherlands)|January 18, 2023
Myeloid-derived suppressor cells inhibit natural killer cells in myelodysplastic syndromes through the TIGIT/CD155 pathwayJing Yue, Jiaojiao Li, Junlan Ma, et al.Hematology (Amsterdam, Netherlands)|January 10, 2023
SARS-CoV-2-infection in the setting of autotransplants for multiple sclerosisJuan Carlos Olivares-Gazca, Robert Peter Gale, Daniela Sánchez-Bonilla, et al.Hematology (Amsterdam, Netherlands)|June 6, 2022
Prevalence and molecular characterization of common thalassemia among people of reproductive age in the border area of Guangxi-Yunnan-Guizhou province in Southwestern ChinaGuiDan Xu, ChunFang Wang, JunLi Wang, et al.Hematology (Amsterdam, Netherlands)|June 6, 2022
MiR-140 targets lncRNA FAM230B to suppress cell proliferation in acute myeloid leukemia running title: MiR-140 targets FAM230B in AMLYan Wang, Fangfang Wang, Yang Lu, et al.Hematology (Amsterdam, Netherlands)|June 29, 2022
Genetic mutations associated with blood count abnormalities in myeloid neoplasmsChantana Polprasert, Sunisa Kongkiatkamon, Pimjai Niparuck, et al.Hematology (Amsterdam, Netherlands)|November 29, 2022
MiR-181a-2-3p as a potential diagnostic and prognostic marker for myelodysplastic syndromeXiaolin Liang, Zeyan Shi, Xiaoke Huang, et al.Hematology (Amsterdam, Netherlands)|June 20, 2022
Detection of abnormal lymphocytes in the peripheral blood of COVID-19 cancer patients: diagnostic and prognostic possibilityLobna Refaat, Mona S Abdellateif, Ahmed Bayoumi, et al.Hematology (Amsterdam, Netherlands)|July 12, 2022
Association between serum calcium and in-hospital mortality in critical patients with multiple myeloma: a cohort studyYafei Mao, Shumin Zhu, Yulan GengHematology (Amsterdam, Netherlands)|September 25, 2010
Lenalidomide: a synthetic compound with an evolving role in cancer managementVassiliki Saloura, Petros D GrivasPageof 265